Pharmacists are warning of an “explosion” in fake weight-loss jabs fuelled by a dearth of Ozempic. Weight-loss medications have soared in popularity as wealthy countries grapple with an obesity crisis. But the UK’s National Pharmacy Association says it is “really worried about fakes in the supply chain”, adding that buyers are risking their health by purchasing the drugs online.
It is urging would-be slimmers and diabetics struggling to obtain the medication to first speak to their pharmacist or GP – and use only regulated providers when buying privately. When the weight-loss properties of type 2 diabetes drug Ozempic were first revealed, there was a surge in off-label prescriptions to dieters, which has led to a global shortage. While Ozempic’s manufacturer Novo Nordisk went on to develop Wegovy as a weight-loss alternative with the same key ingredient, semaglutide, supply difficulties have remained.
This is proving particularly problematic for type 2 diabetics who need Ozempic to help regulate their blood sugar levels. Experts say the shortages are expected into next year, fuelling the illicit trade online. Nick Kaye, chairman of the National Pharmacy Association, said: “Pharmacists remain deeply concerned that the current medicine shortages crisis could lead to an explosion in the unlicensed sale of medication online.
“Stocks of Ozempic are very depleted. It is important that these remain prioritised for those in the most clinical need. “Given the preca.